Tuesday, May 11, 2021
Home Life Style Health & Fitness India Will Have Covid Vaccine by 2020 End: Health Minister

India Will Have Covid Vaccine by 2020 End: Health Minister

Union Minister of Health and Family Welfare Harsh Vardhan said on Saturday that a Covid-19 vaccine is likely in the next 4-5 months

Union Minister of Health and Family Welfare Harsh Vardhan said on Saturday that the country will have a vaccine against the deadly coronavirus by the end of the year.

Speaking to reporters here, he said that a Covid-19 vaccine is likely in the next 4-5 months.

“I hope that if everything goes well, India will have access to a coronavirus vaccine by the end of 2020,” the minister tweeted later.

Follow NewsGram on Facebook to stay updated.

The Ministry of Health and Family Welfare said that one of the three Covid-19 vaccine candidates has entered the third phase of the pre-clinical human trial.

India Will Have Covid Vaccine by 2020 End: Health Minister
The Ministry of Health and Family Welfare said that one of the three Covid-19 vaccine candidates has entered the third phase of the pre-clinical human trial. Unsplash

According to V.K. Paul, head of the national task force on Covid-19, the vaccine candidate entering the third phase has yielded encouraging results in the initial phases of its trial.

Paul said that the other two vaccines are currently in Phase-I or II of their pre-clinical trials.

However, they did not reveal the names of the vaccines while sharing the status of their testing phase.

While the officials did not reveal the names of the vaccine candidates while speaking about their testing phase, it could be gathered that the vaccine entering the third phase is Bharat Biotech’s Covaxin, jointly developed with the Indian Council of Medical Research (ICMR).

India currently has three vaccine candidates for Covid-19 — ChAdOx1, developed by Oxford University and manufactured jointly by the Serum Institute of India (SII), Pune, and AstraZeneca; Bharat Biotech’s Covaxin, jointly developed with the Indian Council of Medical Research; and the third is ZycovD by Zydus Cadila.

The SII had earlier said of starting the Phase 2 trial of its Covid-19 vaccine this week.

It added that it has shortlisted 10 centres across India to host Phase 2 and 3 human clinical trials.

Meanwhile, Zydus Cadila administered the second dose of its Covid-19 vaccine a few days ago.

India Will Have Covid Vaccine by 2020 End: Health Minister
The SII had earlier said of starting the Phase 2 trial of its Covid-19 vaccine this week. Unsplash

The developments on the vaccine came a day after the National Expert Group on Vaccine Administration met five domestic vacine manufacturers to review the clinical trial stages of these candidates. The manufacturers included two whose products are not yet in the clinical trial stage in India.

Also Read: Heart Rate Monitoring Feature Available in 60% Smartwatches Globally

Zydus Cadila had stated in the review meeting that it may be able to launch the vacccine by next year.

According to the Health Ministry, the country recorded 69,878 new coronavirus cases in the last 24 hours, taking the total tally to 29,75,701 on Saturday morning.

During this period, 945 people lost their lives due to Covid-19 infection, taking the death toll to 55,794. (IANS)

STAY CONNECTED

19,511FansLike
362FollowersFollow
1,773FollowersFollow

Most Popular

Knowledge Sharing Social Media Platform For Medical Students: MedBound

We've already been using major social networking sites for different purposes. Well, there are also some social networking sites that aren't to be missed...

Covid19 In India Brought Automation Technologies And IA To The Forefront

The Covid-19 pandemic has brought automation technologies to the forefront and the Intelligent Automation (IA) market in India is estimated to grow at a...

Corset: A Brief History

By- Khushi Bisht Corsets have existed for a very long time. It first originated in Italy and was brought to France in the 16th century...

Hybrid Work Is The Next Big Disruption In US Society

By Dora Mekouar Hybrid schedules could be the next monumental shift in the American workplace after last year's sudden move to remote work. More than 70%...

An Overview Of Bipolar Disorder

BY- JAYA CHOUDHARY Bipolar disorder, also known as bipolar depressive disorder, is a neurological disorder that causes mood and behavior changes. Bipolar disorder is characterized...

Cancer Immunotherapy Approach Targets Common Genetic Alteration

By Blake Jones Researchers have found a prototype for a new kind of immunotherapy for cancer. This therapy uses modified T-cells to target and attack...

Outlook Into Wellness Tourism Growth During Pandemic

The roller coaster ride that was 2020 brought the biggest dip in modern history, forcing individuals to adapt to major lifestyle changes while the...

Strengthen Your Immune System Against Foreign Pathogens

At the personal level, the fight against the Covid-19 virus begins with strong immunity. As the second wave turns out to be more alarming...

Recent Comments